ICU — SeaStar Medical Holding Income Statement
0.000.00%
- $12.90m
- $11.66m
- $0.14m
Annual income statement for SeaStar Medical Holding, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.135 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 0.135 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.108 | 4.45 | 11.6 | 19.2 | 18 |
Operating Profit | -0.108 | -4.45 | -11.6 | -19.2 | -17.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.27 | -4.6 | -12.2 | -26.2 | -24.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.28 | -4.6 | -12.2 | -26.2 | -24.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.28 | -4.6 | -12.2 | -26.2 | -24.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.28 | -4.6 | -12.2 | -26.2 | -24.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -14.6 | -9.05 | -24 | -24.6 | -6.63 |
Dividends per Share |